Company / Working Capital per Share
GeneDx Holdings Corp. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.69
FY2025
5-year range
$5.51 / $3082741.94
FY2021-FY2025
Trend
+3.2%
vs FY2024
Sector context
#77 of 163
Health Care
What the data says
At $5.69, GeneDx Holdings Corp.'s working capital per share ranks #77 of 163 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 3 years of decline, reaching $5.69.
Based on SEC 10-K filings.
5.69 in FY2025 with a 5-year CAGR of -80.4%.
Declined from $10.49 to $5.69 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -92.5%
- 5-Year CAGR
- -80.4%
- 10-Year CAGR
- -
Sector benchmark
#77 of 163 in Health CareTop 47% of 163This company $5.69 Sector average $24.09
▼
-76.4% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 3.2% year-over-year.
- Ranks #77 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.69 | +3.2% |
| FY2024 | $5.51 | -47.5% |
| FY2023 | $10.49 | -99.9% |
| FY2022 | $13316.12 | -99.6% |
| FY2021 | $3082741.94 | +15612.9% |
| FY2020 | $19619.18 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026